Medscape

Experts Challenge FDA Approval of New Donepezil Dose

April 2, 2012 — Approval for the new 23-mg dose of the Alzheimer's disease (AD) drug donepezil (Aricept, Eisai) "breached the FDA's own regulatory standard" and has led to "incomplete and distorted ...
Medscape

FDA Approves High-Dose Donepezil for Advanced Alzheimer's Disease

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
ABC News

FDA Should Ban High Doses of Alzheimer's Drug Aricept, Public Citizen Says

Public Citizen asked the FDA to ban high-dose Aricept because of side effects. May 19, 2011— -- Public Citizen has petitioned the Food and Drug Administration to ban high doses of the Alzheimer's ...
Nasdaq

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of ...

TOKYO, Nov 2, 2022 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a treatment for Alzheimer's disease and dementia with ...
Nasdaq

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Healthline

Your Guide to Treatment Medications for Alzheimer’s Disease

A variety of Alzheimer’s medications can help manage different symptoms and improve quality of life as the disease progresses. Alzheimer’s medications help manage symptoms by improving memory, ...